Effect of ursodeoxycholic acid on hepatotoxicity induced by flutamide during the treatment of prostatic cancer

Nishinihon Journal of Urology

Volumn 59, Issue 5, 1997, Pages 447-449

  Inoue, Wataru ^a   Nakamura, Jun ^a   Azuma, Yutaro ^a   Hongo, Fumiya ^a   Iida, Akio ^a   Watanabe, Makoto ^a   Saitoh, Masahito ^a   Watanabe, Hiroki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Flutamide; Hepatotoxicity; Prostatic cancer; Ursodeoxycholic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FLUTAMIDE; PROSTATE SPECIFIC ANTIGEN; URSODEOXYCHOLIC ACID;

ADULT; AGED; ANOREXIA; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; HUMAN; LIVER DYSFUNCTION; LIVER TOXICITY; MALE; PROSTATE CANCER;

EID: 0030900436     PISSN: 00290726     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Gomez, J. L. et al.: Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am. J. Med. 92. 465-470, 1992
2. Wysowski, D. K. et al : Fatal and nonfatal hepatotoxicity associated with flutamide. Ann. Intern Med. 118: 860-864, 1993.
3. Wysowski, D. K. et al.: Flutamide hepatotoxicity. J. Urol. 155: 209-212, 1996.